Clinical Trial Update: Spironolactone After Liver Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on spironolactone after liver transplant completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Liver Transplant Complications

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Transplant, Liver | Phase 4 | Status: COMPLETED | Results posted: 2021-06-29